Skip to main content
Journal cover image

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Publication ,  Journal Article
Hirsh, J; Warkentin, TE; Raschke, R; Granger, C; Ohman, EM; Dalen, JE
Published in: Chest
November 1998

Duke Scholars

Published In

Chest

DOI

ISSN

0012-3692

Publication Date

November 1998

Volume

114

Issue

5 Suppl

Start / End Page

489S / 510S

Location

United States

Related Subject Headings

  • Respiratory System
  • Humans
  • Heparin, Low-Molecular-Weight
  • Heparin
  • Drug Monitoring
  • Anticoagulants
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998). Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest, 114(5 Suppl), 489S-510S. https://doi.org/10.1378/chest.114.5_supplement.489s
Hirsh, J., T. E. Warkentin, R. Raschke, C. Granger, E. M. Ohman, and J. E. Dalen. “Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.Chest 114, no. 5 Suppl (November 1998): 489S-510S. https://doi.org/10.1378/chest.114.5_supplement.489s.
Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1998 Nov;114(5 Suppl):489S-510S.
Hirsh, J., et al. “Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.Chest, vol. 114, no. 5 Suppl, Nov. 1998, pp. 489S-510S. Pubmed, doi:10.1378/chest.114.5_supplement.489s.
Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1998 Nov;114(5 Suppl):489S-510S.
Journal cover image

Published In

Chest

DOI

ISSN

0012-3692

Publication Date

November 1998

Volume

114

Issue

5 Suppl

Start / End Page

489S / 510S

Location

United States

Related Subject Headings

  • Respiratory System
  • Humans
  • Heparin, Low-Molecular-Weight
  • Heparin
  • Drug Monitoring
  • Anticoagulants
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences